Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Editorial Expression of Concern: Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia.
Journal: Leukemia
Published: May 06, 2026
Proximity-Induced Rewiring of Oncogenic Kinase Triggers Apoptosis.
Journal: ACS central science
Published: November 19, 2025
A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia.
Journal: Molecular therapy. Oncology
Published: November 04, 2025
Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain.
Journal: European journal of medicinal chemistry
Published: August 08, 2025
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemia.
Journal: Nature reviews. Clinical oncology
Published: July 30, 2025
Spatial Biology and Organoid Technologies Reveal a Potential Therapy-Resistant Cancer Stem Cell Population in Pancreatic Ductal Adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Phosphorylation-inducing chimera rewires oncogenic kinase to trigger apoptosis.
Journal: bioRxiv : the preprint server for biology
Published: July 15, 2025
Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy.
Journal: Molecular therapy. Oncology
Published: April 15, 2025
Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs.
Journal: Molecular therapy. Oncology
Published: October 05, 2024
Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.
Journal: Cancers
Published: March 17, 2024
BRD9 regulates normal human hematopoietic stem cell function and lineage differentiation.
Journal: Cell death and differentiation
Published: February 26, 2024
Last Updated: 09/26/2026